Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Imianowski CJ"" wg kryterium: Autor


Wyświetlanie 1-2 z 2
Tytuł:
CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function.
Autorzy:
Whiteside SK; Department of Pathology, University of Cambridge, Cambridge, UK.; Immunology Programme, Babraham Research Campus, Babraham Institute, Cambridge, UK.
Grant FM; Immunology Programme, Babraham Research Campus, Babraham Institute, Cambridge, UK.
Gyori DS; Department of Physiology, Semmelweis University, Budapest, Hungary.
Conti AG; Department of Pathology, University of Cambridge, Cambridge, UK.
Imianowski CJ; Department of Pathology, University of Cambridge, Cambridge, UK.; Immunology Programme, Babraham Research Campus, Babraham Institute, Cambridge, UK.
Kuo P; Department of Pathology, University of Cambridge, Cambridge, UK.; Immunology Programme, Babraham Research Campus, Babraham Institute, Cambridge, UK.
Nasrallah R; Immunology Programme, Babraham Research Campus, Babraham Institute, Cambridge, UK.
Sadiyah F; Department of Pathology, University of Cambridge, Cambridge, UK.; Immunology Programme, Babraham Research Campus, Babraham Institute, Cambridge, UK.
Lira SA; Mount Sinai School of Medicine, Immunology Institute, New York, NY, USA.
Tacke F; Department of Hepatology & Gastroenterology, Campus Virchow-Klinikum (CVK) and Campus Charité Mitte (CCM), Charité Universitätsmedizin Berlin, Berlin, Germany.
Eil RL; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Burton OT; Immunology Programme, Babraham Research Campus, Babraham Institute, Cambridge, UK.
Dooley J; Immunology Programme, Babraham Research Campus, Babraham Institute, Cambridge, UK.
Liston A; Immunology Programme, Babraham Research Campus, Babraham Institute, Cambridge, UK.
Okkenhaug K; Department of Pathology, University of Cambridge, Cambridge, UK.
Yang J; Department of Pathology, University of Cambridge, Cambridge, UK.; Immunology Programme, Babraham Research Campus, Babraham Institute, Cambridge, UK.
Roychoudhuri R; Department of Pathology, University of Cambridge, Cambridge, UK.; Immunology Programme, Babraham Research Campus, Babraham Institute, Cambridge, UK.
Pokaż więcej
Źródło:
Immunology [Immunology] 2021 Aug; Vol. 163 (4), pp. 512-520. Date of Electronic Publication: 2021 May 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma/*immunology
Colorectal Neoplasms/*immunology
Lymphocytes, Tumor-Infiltrating/*immunology
Melanoma/*immunology
Receptors, CCR8/*metabolism
Skin Neoplasms/*immunology
T-Lymphocytes, Regulatory/*immunology
Animals ; Forkhead Transcription Factors/metabolism ; Humans ; Immune Tolerance ; Melanoma, Experimental ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Receptors, CCR8/genetics
Czasopismo naukowe
Tytuł:
A cell-based bioluminescence assay reveals dose-dependent and contextual repression of AP-1-driven gene expression by BACH2.
Autorzy:
Vardaka P; Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK.; Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, CB22 3AT, UK.
Lozano T; Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, CB22 3AT, UK.
Bot C; CRUK Therapeutic Discovery Laboratories, Babraham Research Campus, Cambridge, CB22 3AT, UK.
Ellery J; CRUK Therapeutic Discovery Laboratories, Babraham Research Campus, Cambridge, CB22 3AT, UK.
Whiteside SK; Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK.; Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, CB22 3AT, UK.
Imianowski CJ; Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK.; Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, CB22 3AT, UK.
Farrow S; CRUK Therapeutic Discovery Laboratories, Babraham Research Campus, Cambridge, CB22 3AT, UK.
Walker S; Imaging Facility, Babraham Institute, Cambridge, CB22 3AT, UK.
Okkenhaug H; Imaging Facility, Babraham Institute, Cambridge, CB22 3AT, UK.
Yang J; Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK.; Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, CB22 3AT, UK.
Okkenhaug K; Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK.
Kuo P; Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK.; Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, CB22 3AT, UK.
Roychoudhuri R; Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK. .; Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, CB22 3AT, UK. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Nov 03; Vol. 10 (1), pp. 18902. Date of Electronic Publication: 2020 Nov 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Acrylamides/*pharmacology
Basic-Leucine Zipper Transcription Factors/*genetics
Luminescent Measurements/*methods
Phenylenediamines/*pharmacology
Tetradecanoylphorbol Acetate/*analogs & derivatives
Transcription Factor AP-1/*genetics
Animals ; Cell Differentiation ; Dose-Response Relationship, Drug ; Gene Expression Regulation/drug effects ; Humans ; Jurkat Cells ; Luciferases/genetics ; Luciferases/metabolism ; Mice ; Tetracycline/pharmacology ; Tetradecanoylphorbol Acetate/pharmacology
Czasopismo naukowe
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies